IGC Pharma (IGC) EBIT Margin Growth (3y) (2013 - 2025)
IGC Pharma (IGC) EBIT Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-28,612.00 |
| Jun 30, 2025 |
74,091.00 |
| Mar 31, 2025 |
-516,097.00 |
| Dec 31, 2024 |
94,884.00 |
| Sep 30, 2024 |
733,710.00 |
| Jun 30, 2024 |
196,847.00 |
| Mar 31, 2024 |
-338,040.00 |
| Dec 31, 2023 |
68,410.00 |
| Sep 30, 2023 |
48,479.00 |
| Jun 30, 2023 |
-5,475.00 |
| Mar 31, 2023 |
-686,635.00 |
| Dec 31, 2022 |
-39,330.00 |
| Sep 30, 2022 |
-116,095.00 |
| Jun 30, 2022 |
-123,346.00 |
| Mar 31, 2022 |
459,757.00 |
| Dec 31, 2021 |
-155,678.00 |
| Sep 30, 2021 |
-765,886.00 |
| Jun 30, 2021 |
-281,478.00 |
| Mar 31, 2021 |
510,326.00 |
| Dec 31, 2020 |
-209,163.00 |
